Elizabeth Vroom

Elizabeth Vroom

Auto-generated profile, based on publicly available information

Elizabeth Vroom

Duchenne Parent Project, World Duchenne Organization , The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2016 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
KKKatrijn Klingels
Katrijn Klingels
AMA G Mayhew
A G Mayhew
EME S Mazzone
E S Mazzone
TDTina Duong
Tina Duong
VDV Decostre
V Decostre
TGThe Upper Limb Clinical Outcome Group
The Upper Limb Clinical Outcome Group
Aim: To develop a patient‐reported outcome measure (PROM) assessing upper limb function related to activities of daily living (ADL) that cannot be observed in a clinical setting, specifically for patients with Duchenne muscular dystrophy (DMD) across a wide age range, applicable in the different stages of the disease.Method: The developmental process was based on US Food and Drug Administration guidelines. This included item generation from a systematic review of existing tools and expert opinion on task difficulty and relevance, involving individuals with DMD. Cultural aspects affecting ADL were taken into consideration to make this tool applicable to the broad DMD community. Items were selected in relation to a conceptual framework reflecting disease progression covering the full range of upper limb function across different ADL domains.Results: After pilot testing and iterative Rasch analyses, redundant or clinically irrelevant items were removed. The final questionnaire consists of 32 items covering four domains of ADL (food, self‐care, household and environment, leisure and communication). Test–retest reliability was excellent.Interpretation: A DMD‐specific upper limb PROM was developed on the basis of clinical relevance and psychometric robustness. Its main purpose is to document the patient self‐reported natural history of DMD and assess the efficacy of interventions.

4 October 2023 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
EKEva Willemijn Hélène Korte
Eva Willemijn Hélène Korte
PSPhyllis I Spuls
Phyllis I Spuls
PAPeter C van den Akker
Peter C van den Akker
DKDimitra Kiritsi
Dimitra Kiritsi
MLMartin Laimer
Martin Laimer
MBM.C. Bolling
M.C. Bolling
The COSEB kick-off meeting was organized in April 2023, and highlighted the stakeholder perspectives on the unmet and urgent need to work towards reasonable harmonization of outcome measurement in epidermolysis bullosa (EB) by developing core outcome sets for the different EB types. Standardized and uniform outcome assessment holds great promise to reduce selective reporting, improve the comparability and pooling of treatment outcomes, and enhance the efficacy of future research in EB.

1 July 2018 in Neuromuscular Disorders
Verified
Journal Article
Closed access
AAAnnemieke Aartsma-Rus
Annemieke Aartsma-Rus
EMEugenio Mercuri
Eugenio Mercuri
EVElizabeth Vroom
Elizabeth Vroom
PBPavel Balabanov
Pavel Balabanov

3 October 2023 in Neuromuscular Disorders
Verified
Journal Article
Closed access
PHP. 'T Hoen
P. 'T Hoen
NLN. Lalout
N. Lalout
EVE. Vroom
E. Vroom
MFM. Franken
M. Franken
DJD. Jäger
D. Jäger
MWM. Wilkinson
M. Wilkinson